Literature DB >> 3221218

Low leukocyte glutamate dehydrogenase activity does not correlate with a particular type of multiple system atrophy.

R C Duvoisin1, W J Nicklas, V Ritchie, J Sage, S Chokroverty.   

Abstract

Leucocyte glutamate dehydrogenase (GDH) activity was measured in 26 normal control subjects, 20 patients with multiple system atrophy presenting features of either olivopontocerebellar atrophy or striatonigral degeneration and in a heterogenous group of 15 patients with spinocerebellar degenerations. A broad range of GDH activity was found in all three groups. Low activity failed to correlate with a specific clinical entity. Patients followed to post-mortem examination to date have demonstrated histological features of at least three distinct morbid entities. It is concluded, contrary to earlier reports including the authors', that low leukocyte GDH activity does not identify a particular type of multiple system atrophy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3221218      PMCID: PMC1032765          DOI: 10.1136/jnnp.51.12.1508

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Neuronal intranuclear hyaline inclusion disease associated with premature coronary atherosclerosis.

Authors:  J C Parker; M L Dyer; W A Paulsen
Journal:  J Clin Neuroophthalmol       Date:  1987-12

Review 2.  The olivopontocerebellar atrophies: a review.

Authors:  B W Konigsmark; L P Weiner
Journal:  Medicine (Baltimore)       Date:  1970-05       Impact factor: 1.889

3.  Juvenile Parkinsonism treated with levodopa.

Authors:  A W Kilroy; W A Paulsen; G M Fenichel
Journal:  Arch Neurol       Date:  1972-10

4.  Neurological disorders associated with deficiency of glutamate dehydrogenase.

Authors:  A Plaitakis; S Berl; M D Yahr
Journal:  Ann Neurol       Date:  1984-02       Impact factor: 10.422

5.  Glutamate dehydrogenase and its isozyme activity in olivopontocerebellar atrophy.

Authors:  Y Konagaya; M Konagaya; T Takayanagi
Journal:  J Neurol Sci       Date:  1986-07       Impact factor: 3.181

6.  Glutamate dehydrogenase deficiency in three patients with spinocerebellar syndrome.

Authors:  A Plaitakis; W J Nicklas; R J Desnick
Journal:  Ann Neurol       Date:  1980-04       Impact factor: 10.422

7.  Corticodentatonigral degeneration with neuronal achromasia.

Authors:  J J Rebeiz; E H Kolodny; E P Richardson
Journal:  Arch Neurol       Date:  1968-01

8.  Glutamate dehydrogenase deficiency in patients with olivopontocerebellar atrophy.

Authors:  R C Duvoisin; S Chokroverty; F Lepore; W Nicklas
Journal:  Neurology       Date:  1983-10       Impact factor: 9.910

9.  Glutamate dehydrogenase deficiency in spinocerebellar degenerations.

Authors:  T Yamaguchi; K Hayashi; H Murakami; K Ota; S Maruyama
Journal:  Neurochem Res       Date:  1982-05       Impact factor: 3.996

10.  Abnormal platelet glutamate dehydrogenase activity and activation in dominant and nondominant olivopontocerebellar atrophy.

Authors:  S Sorbi; S Tonini; E Giannini; S Piacentini; P Marini; L Amaducci
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

View more
  4 in total

1.  Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord.

Authors:  S Malessa; P N Leigh; O Bertel; E Sluga; O Hornykiewicz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

2.  DIDMOAD syndrome; further studies and muscle biochemistry.

Authors:  T G Barrett; K Poulton; S Bundey
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Multiple system degeneration with glutamate dehydrogenase deficiency: pathology and biochemistry.

Authors:  S Chokroverty; W Nicklas; D C Miller; J Goldberg; J Choe; C Banner; J Thomas; R Duvoisin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

Review 4.  Neuropathology in movement disorders.

Authors:  W R Gibb
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.